Tomas Philipson
Names
first: |
Tomas |
middle: |
J |
last: |
Philipson |
Contact
Affiliations
-
University of Chicago
→ Harris School of Public Policy
- website
- location: Chicago, Illinois (United States)
-
National Bureau of Economic Research (NBER)
- website
- location: Cambridge, Massachusetts (United States)
-
Manhattan Institute
- website
- location: New York, New York (United States)
-
American Enterprise Institute
- website
- location: Washington, District of Columbia (United States)
Research profile
author of:
-
Antitrust and the Not-For-Profit Sector
by Tomas J. Philipson & Richard A. Posner
-
Merit Motives and Government Intervention: Public Finance in Reverse
by Casey B. Mulligan & Tomas J. Philipson
-
The Economic Epidemiology of Crime.
by Philipson, Tomas J. & Posner, Richard A.
-
Equilibrium and Efficiency in an Organized Vote Market.
by Philipson, Tomas J. & Snyder, James M., Jr
-
The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
by Frank R. Lichtenberg & Tomas J. Philipson
-
Self-Interested Treatment Evaluation in Experiments
by Tomas J. Philipson
-
External Treatment Effects and Program Implementation Bias
by Tomas J. Philipson
-
The Long-Run Growth in Obesity as a Function of Technological Change
by Tomas J. Philipson & Richard A. Posner
-
Managed Care and the Quality of Health Care: A Misguided Debate?
by Philipson, Thomas
-
Longevity Complementarities under Competing Risks
by Tomas J. Philipson & William H. Dow & Xavier Sala-i-Martin
-
Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
by Tomas J. Philipson & Anupam B. Jena
-
Pricing and R&D When Consumption Affects Longevity
by Pierre-Yves Geoffard & Tomas Philipson
-
Economic epidemiology and infectious diseases
by Philipson, Tomas
edited by
-
Intellectual Property and Marketing
by Darius Lakdawalla & Tomas Philipson & Y. Richard Wang
-
The Future of Old-Age Longevity: Competitive Pricing of Mortality Contingent Claims
by Charles Mullin & Tomas Philipson
-
Welfare-Enhancing Technological Change and the Growth of Obesity
by Darius Lakdawalla & Tomas Philipson & Jay Bhattacharya
-
Measurement errors: A principal investigator-agent approach
by Philipson, Tomas & Malani, Anup
-
Multiple-output agency incentives in data production: experimental evidence
by Philipson, Tomas & Lawless, Thomas
-
Economic Epidemiology and Infectious Diseases
by Tomas Philipson
-
Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS
by Avner Ahituv & V. Joseph Hotz & Tomas Philipson
-
Observational Agency and Supply-Side Econometrics
by Tomas Philipson
-
Subject Evaluation in Social Experiments
by Tomas Philipson & Larry V. Hedges
-
Health Care, Technological Change, and Altruistic Consumption Externalities
by Tomas Philipson & Stephane Mechoulan & Anupam Jena
-
Surplus Appropriation from R&D and Health Care Technology Assessment Procedures
by Tomas J. Philipson & Anupam B. Jena
-
Death, tetanus, and aerobics: The evaluation of disease-specific health interventions
by William H. Dow & Jessica Holmes & Tomas Philipson & Xavier Sala-i-Martin
-
Rational Epidemics and their Public Control.
by Geoffard, P. Y. & Philipson, T.
-
The nonprofit sector and industry performance
by Lakdawalla, Darius & Philipson, Tomas
-
An Empirical Examination of Information Barriers to Trade inInsurance
by John Cawley & Tomas Philipson
-
The Rise in Old Age Longevity and the Market for Long-Term Care
by Thomas Philipson & Darius Lakdawalla
-
Social Welfare and Measurement of Segregation
by Philipson Tomas
-
Data Markets, Missing Data, and Incentive Pay.
by Philipson, Tomas
-
Pricing and R&D with Related Margins
by Geoffard, P. Y. & Philipson, T.
-
An empirical examination of the implications of assortative matching on the incidence of HIV
by Dow, William H. & Philipson, Tomas
-
Public Spending on AIDS Education: An Economic Analysis.
by Philipson, Tomas & Posner, Richard A.
-
Is Health Care Technology Over-Approved? A Meta-Analysis of Revealed Preference
by Larry V. Hedges & Tomas Philipson
-
The evaluation of new health care technology: The labor economics of statistics
by Philipson, Tomas
-
Rational Epidemics and Their Public Control.
by Geoffard, Pierre-Yves & Philipson, Tomas
-
Disease Complementarities and the Evaluation of Public Health Interventions
by William H. Dow & Jessica Holmes & Tomas Philipson & Xavier Sala-i-Martin
-
The Quantity and Quality of Life and the Evolution of World Inequality
by Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares
-
Old-Age Longevity and Mortality-Contingent Claims
by Tomas J. Philipson & Gary S. Becker
-
Mortality Contingent Claims, Health Care, and Social Insurance
by Tomas Philipson & Gary S. Becker
-
Merit Motives and Government Intervention: Public Finance in Reverse
by Casey Mulligan & Tomas Philipson
-
Nonprofit Production.
by Tomas Philipson & Darius Lakdawalla
-
Estimating the Extent of Trade Under Incomplete Information: The Case of HIV
by Tomas Philipson & Edward Vytlacil
-
The Private Demand for Information and the Effects of Public Testing Programs: The Case of HIV.
by Boozer, M. & Philipson, T.
-
The Future of Old-Age Longevity: Competitive Pricing of Morality Contingent Claims
by Charles Mullin & Tomas Philipson
-
Disease Eradication: Private versus Public Vaccination.
by Geoffard, Pierre-Yves & Philipson, Tomas
-
Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
by Tomas J. Philipson & Anupam B. Jena
-
Nonprofit Production and Competition
by Darius Lakdawalla & Tomas Philipson
-
Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
by Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson & Matthew W. Strobeck
-
An Empirical Examination of Information Barriers to Trade in Insurance
by Tomas Philipson & John Cawley
-
Data MArkets and OPtimal Sample Size Determination
by Geoffard, P. Y. & Philipson, T.
-
Aging and the Growth of Long-Term Care
by Darius Lakdawalla & Tomas Philipson
-
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
by Darius Lakdawalla & Tomas Philipson
-
Health investment complementarities under competing risks
by William H. Dow & Tomas Philipson & Xavier Sala-i-Martin & Jessica Holmes
-
An Empirical Examination of Information Barriers to Trade in Insurance
by John Cawley & Tomas Philipson
-
Assessing the Safety and Efficacy of the FDA: The Case of the Prescription Drug User Fee Acts
by Tomas J. Philipson & Ernst R. Berndt & Adrian H. B. Gottschalk & Matthew W. Strobeck
-
Antitrust in the Not-For-Profit Sector
by Tomas J. Philipson & Richard A. Posner
-
Intellectual Property & External Consumption Effects: Generalizations from Pharmaceutical Markets
by Tomas Philipson & Stephane Mechoulan
-
Disease Eradication: Private vs. Public Vaccination.
by Geoffard, P. Y. & Philipson, T.
-
The welfare loss of disease and the theory of taxation
by Philipson, Tomas
-
The Quantity and Quality of Life and the Evolution of World Inequality
by Gary S. Becker & Tomas J. Philipson & Rodrigo R. Soares
-
Consumption vs. Production of Insurance
by Tomas Philipson & George Zanjani
-
The Rise in Old Age Longevity and the Market for Long-Term Care
by Darius Lakdawalla & Tomas Philipson
-
Death, Tetanus and Aerobics: The Evaluation of Disease-Specific Health Interventions
by Holmes, Jessica & Philipson, Tomas & Sala-i-Martin, Xavier & Tahvonen, Olli
-
Mortality Contingent Claims, Health Care, and Social Insurance
by Tomas Philipson & Gary S. Becker
-
The Value of Life Near its End and Terminal Care
by Gary Becker & Kevin Murphy & Tomas Philipson
-
Is the Food and Drug Administration Safe and Effective?
by Tomas J. Philipson & Eric Sun
-
Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity
by Tomas Philipson & Richard Posner
-
Integrated Insurance Design in the Presence of Multiple Medical Technologies
by Dana Goldman & Tomas Philipson
-
The Value of Life in General Equilibrium
by Anupam Jena & Casey Mulligan & Tomas J. Philipson & Eric Sun
-
Medical Care Output and Productivity in the Nonprofit Sector
by Tomas Philipson & Darius Lakdawalla
edited by
-
Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
by Ernst R. Berndt & Adrian H. B. Gottschalk & Tomas Philipson
edited by
-
Asymmetric Information and the Not-for-Profit Sector Does Its Output Sell a a Premium?
by Tomas Philipson
edited by
-
Theories of Firm Behavior in the Nonprofit Sector. A Synthesis and Empirical Evaluation
by Anup Malani & Tomas Philipson & Guy David
edited by
-
Endogenous Cost-Effectiveness Analysis in Health Care Technology Adoption
by Anupam Jena & Tomas Philipson
-
Is the Food And Drug Administration Safe And Effective?
by Tomas J. Philipson & Eric Sun
-
The Rise in Old-Age Longevity and the Market for Long-Term Care
by Darius Lakdawalla & Tomas Philipson
-
Aging and the Growth of Long-Term Care
by Darius Lakdawalla & Tomas Philipson
-
The institute of medicine report on the FDA: where is the science?
by Tomas Philipson & Anupam B. Jena & Eric Sun
-
The Value of Life Near its End and Terminal Care
by Gary Becker & Kevin Murphy & Tomas Philipson
-
Will the AIDS Epidemic be Self-Limiting? Evidence on the Responsiveness of the Demand for Condoms to the Prevalence of AIDS
by Avner Ahituv & V. Joseph Hotz & Tomas Philipson
-
The Long-Run Growth in Obesity as a Function of Technological Change
by Tomas J. Philipson & Richard A. Posner
-
Labor Supply and Weight
by Darius Lakdawalla & Tomas Philipson
-
Integrated Insurance Design in the Presence of Multiple Medical Technologies
by Tomas J. Philipson & Dana Goldman
-
Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy
by Tomas J. Philipson & Richard A. Posner
-
Public Financing and the Market for Long-Term Care
by Darius Lakdawalla & Thomas Philipson
edited by
-
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination
by Darius Lakdawalla & Tomas Philipson
-
The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in the US
by Frank R. Lichtenberg & Tomas J. Philipson
-
Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
by Philipson, Tomas & Berndt, Ernst R. & Gottschalk, Adrian H. B. & Sun, Eric
-
Dynamic information release
by Tomas Philipson
-
External Treatment Effects and Program Implementation Bias
by Tomas Philipson
-
Cost-effectiveness analysis and innovation
by Jena, Anupam B. & Philipson, Tomas J.
-
Antitrust in the Not-for-Profit Sector
by Tomas J. Philipson & Richard A. Posner
-
The world‐wide growth in obesity: an economic research agenda
by Tomas Philipson
-
An Economic Evaluation of the War on Cancer
by Eric C. Sun & Anupam B. Jena & Darius N. Lakdawalla & Carolina M. Reyes & Tomas J. Philipson & Dana P. Goldman
-
The Effects of Product Liability Exemption in the Presence of the FDA
by Tomas J. Philipson & Eric C. Sun & Dana Goldman
-
The Impact of Comparative Effectiveness Research on Health and Health Care Spending
by Anirban Basu & Tomas J. Philipson
-
Terminal Care and The Value of Life Near Its End
by Tomas J. Philipson & Gary Becker & Dana Goldman & Kevin M. Murphy
-
`Me-Too' Innovation in Pharmaceutical Markets
by Jena Anupam B. & Calfee John E. & Mansley Edward C. & Philipson Tomas J.
-
Public Financing and the Market for Long-Term Care
by Lakdawalla Darius & Philipson Thomas
-
Assessing the Impacts of the Prescription Drug User Fee Acts (PDUFA) on the FDA Approval Process
by Berndt Ernst R. & Gottschalk Adrian H. B. & Philipson Tomas & Strobeck Matthew W.
-
Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs
by Philipson Tomas J. & Jena Anupam B.
-
The Effects of Product Liability Exemption in the Presence of the FDA
by Tomas J. Philipson & Eric Sun & Dana Goldman
edited by
-
"Me-Too" Innovation in Pharmaceutical Markets
by Anupam B. Jena & John E. Calfee & Edward C. Mansley & Tomas J. Philipson
edited by
-
Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets
by Anup Malani & Tomas J. Philipson
-
Public Liabilities and Health Care Policy
by Kristopher J. Hult & Tomas J. Philipson
-
Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension
by Tomas J. Philipson & George Zanjani
-
Adjusting National Accounting for Health: Is the Business Cycle Countercyclical?
by Mark L. Egan & Casey B. Mulligan & Tomas J. Philipson
-
International Health Economics
by Mark Egan & Tomas J. Philipson
-
Financial Health Economics
by Ralph Koijen & Tomas Philipson & Harald Uhlig
-
Health Care Adherence and Personalized Medicine
by Mark Egan & Tomas J. Philipson
-
How Does Technological Change Affect Quality-Adjusted Prices in Health Care? Systematic Evidence from Thousands of Innovations
by Kristopher J. Hult & Sonia Jaffe & Tomas J. Philipson
-
Sharing R&D Risk in Healthcare via FDA Hedges
by Adam Jørring & Andrew W. Lo & Tomas J. Philipson & Manita Singh & Richard T. Thakor
-
The Economic Value and Pricing of Personalized Medicine
by Tomas J. Philipson
edited by